Neuroscience Market Report 2025

The neuroscience market size has grown strongly in recent years. It will grow from $35.51 billion in 2024 to $37.58 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased funding for neuroscience research, emergence of neuroinformatic, genomic and proteomic research in neuroscience, public awareness and education, drug discovery and development, global aging population, neuroscience-based education and learning.

The neuroscience market size is expected to see strong growth in the next few years. It will grow to $50.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine in neurological treatments, expansion of neuropharmacology, neuroinformatic for big data management, patient-centric approaches in neurological care, global health initiatives for neurological disorders, innovations in neurological diagnostics, ethical considerations, and guidelines. Major trends in the forecast period include brain imaging technologies, neurostimulation therapies, artificial intelligence in neuroscience, brain-computer interface (BCI) technology, telemedicine in neurology, collaboration between industry and academia, cross-disciplinary approaches.

The increasing geriatric population is expected to boost the neuroscience market. Individuals aged 65 years and older are classified as part of the geriatric population. Due to reduced immunity and advancing age, this group is more vulnerable to various diseases, including neurological disorders. Common neurological conditions affecting older adults include lumbar arthrosis and dementia, both of which can be addressed through neuroscience. For example, a report by the United Nations, a US-based diplomatic and political international organization, stated in July 2022 that the global population aged 65 and older is projected to rise from 10% in 2022 to 16% by 2050, indicating a significant increase in this age group worldwide by mid-century. Therefore, the growing geriatric population is a key driver of the neuroscience market.

The rising incidence of neurological disorders, particularly Alzheimer’s disease, is expected to drive growth in the neuroscience market. Neurological disorders encompass a wide range of medical conditions that primarily impact the nervous system, including the brain, spinal cord, and peripheral nerves. Alzheimer’s disease is a progressive neurodegenerative disorder that significantly affects cognitive function and memory. Neuroscience plays a crucial role in understanding and treating Alzheimer’s disease; by examining the structure and function of the nervous system, neuroscientists are uncovering the underlying causes of AD and developing new approaches for diagnosis, prevention, and treatment. For instance, a report by the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer's care, support, and research, revealed in May 2024 that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of neurological disorders, such as Alzheimer’s disease, is a significant driver of the neuroscience market.

Technological advancement is a significant trend gaining traction in the neuroscience market. Leading companies are focusing on developing innovative technologies such as artificial intelligence (AI) and machine learning to enhance neuroscience. AI allows machines to replicate and even exceed human cognitive abilities, with machine learning being a subset of AI. AI models are designed to perform intelligence-driven tasks, offering new insights into how similar processes are regulated within the brain. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology firm, partnered with Synthetic MR, a Sweden-based MRI software company, to launch Smart Quant Neuro 3D. This groundbreaking tool is designed for diagnosing and assessing brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. The solution combines Philips’ AI-powered SmartSpeed technology, the 3D SyntAc application, and Synthetic MR's SyMRI NEURO 3D software, providing healthcare providers with enhanced diagnostic capabilities to improve confidence and patient outcomes. Philips has exclusive rights to offer SyMRI NEURO 3D on its MR scanners.

Major companies operating in the neuroscience sector are concentrating on launching innovative products, such as brain implant technology, to maintain their competitive edge in the market. Brain implant technology involves devices that are directly inserted into the brain to interact with neural tissue, facilitating the stimulation, monitoring, or modulation of brain activity. For example, in October 2022, Axoft, a health technology company based in the U.S., introduced a groundbreaking brain implant technology designed for the treatment of long-term neurological disorders, which received FDA Breakthrough Device Designation. Their innovative gliosis-free implants can safely remain in the central nervous system over the long term, providing electrical stability and an ultra-high density of sensors for improved brain-electronics communication. Axoft’s minimally invasive implants offer high-bandwidth, stable single-neuron measurements and can adapt to changes in the brain, ensuring long-term functionality without the need for frequent replacements, making them particularly suitable for brain-machine interfaces (BMI).

In March 2022, AbbVie, a biopharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an undisclosed sum. AbbVie's objective behind this acquisition was to bolster its neuroscience portfolio by gaining access to Syndesi's range of advanced SV2A modulators, notably their flagship drug SDI-118. Syndesi Therapeutics SA, headquartered in Belgium, specializes in drug discovery within the field of neurology within the biotechnology sector.

Major companies operating in the neuroscience market are Alpha Omega Inc., General Electric Company, Siemens Healthineers AG, NeuroNexus Technologies Inc., Doric Lenses Inc., Blackrock Neurotech, Axion Biosystems Inc., Femtonics Ltd., Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corporation, Scientifica Ltd., Intan Technologies Inc., Laserglow Technologies Inc., Mightex Systems, Neuralink Corporation, Kernel Corporation, BrainCo Inc., MindMaze Inc., Paradromics Inc., NeuroPro Inc., NeuroSky Inc., EMOTIV Inc., Cercare Medical A/S, Plexon Inc., Noldus Information Technology bv, Neuralynx Inc., Vigil Neuroscience.

North America was the largest region in the neuroscience market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroscience market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroscience market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neuroscience, delving into the intricacies of the human nervous system and brain, integrates cellular and molecular biology, anatomy, physiology, human behavior, cognition, and related fields to comprehensively map brain functionalities. Its applications extend to the development of pharmaceuticals, treatments, and preventive methodologies for various health conditions, offering solutions to a spectrum of health concerns.

Diverse branches within neuroscience encompass neuro-microscopy, electrophysiology technologies, neuro-cellular manipulation, whole brain imaging, and other specialized tools provided through instruments, consumables, software, and services. Neuro-microscopy, tailored for surgeries involving the brain, spinal cord, and spine, serves as an operating microscope. It facilitates illumination and magnification of deeper surgical fields, equipped with features like a binocular head with adjustable eyepieces and foot controls, ensuring enhanced precision and maneuverability. The application of neuroscience spans across hospitals, diagnostic labs, research facilities, and academic institutes, supporting various scientific endeavors and medical advancements.

The neuroscience market research report is one of a series of new reports that provides neuroscience market statistics, including neuroscience industry global market size, regional shares, competitors with a neuroscience market share, detailed neuroscience market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience industry. This neuroscience market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroscience market consists of the revenues earned by consulting services, installation services, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.